[Clinical study of three-dose regimen of Zenapax in orthotopic liver transplantation].

Abstract

OBJECTIVES:

To observe the clinical efficacy and safety of three-dose regimen of Zenapax combined with tacrolimus (FK506), mycophenolate mofetil (MMF), and steroid in the early-stage management of liver transplantation.

METHOD:

Thirteen liver transplantation recipients received the same immunosuppression regimen with three-dose Zenapax combined with FK506, MMF, and steroid. The incidence of acute allograft rejection (AR), blood concentration and dosage of FK506, and the liver graft function were observed in the 30 days after liver transplantation and compared with the results documented in literatures.

RESULTS:

One patient developed AR 17 days after transplantation and 3 patients died on the postoperative days 14, 19 and 23, respectively, due to pulmonary fungal infection, acute hepatic failure or multiple organ failure resulting from stenosis and thrombosis of hepatic artery respectively. Ten recipients had various infections. An average of 16.56+/-10.40 d was taken for functional recovery of the liver graft, and the blood concentration of FK506 was maintained at (10.25+/-1.99)x10(-3) mg/L. Anaphylaxis, post-transplant lymphoproliferative disorder (PTLD), or other adverse effects were not observed.

CONCLUSION:

Three-dose regimen of Zenapax in combination with FK506, MMF and steroid is safe and effective in the postoperative management of orthotopic liver transplantation.

• Authors: Gang He, Li-xing Yu, Wen-feng Deng
• Journal: Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA (Di Yi Jun Yi Da Xue Xue Bao) Vol. 24 Issue 7 Pg. 729-32 (Jul 2004) ISSN: 1000-2588 [Print] China
• PMID: 15257886 (Publication Type: Journal Article)

Chemical References

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Immunoglobulin G
• Immunosuppressive Agents
• Daclizumab
• Mycophenolic Acid
• Tacrolimus

Topics

• Adult
• Aged
• Antibodies, Monoclonal (administration & dosage, adverse effects)
• Antibodies, Monoclonal, Humanized
• Daclizumab
• Drug Therapy, Combination
• Female
• Graft Rejection
• Humans
• Immunoglobulin G (administration & dosage, adverse effects)
• Immunosuppressive Agents (administration & dosage)
• Liver Transplantation (mortality)
• Male
• Middle Aged
• Mycophenolic Acid (administration & dosage, analogs & derivatives)
• Survival Rate
• Tacrolimus (administration & dosage, blood)